Top Trends Transforming the Analgesics Market Landscape in 2025: Strategic Investments In The Analgesics Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Analgesics Market Size By 2025?
The market size for analgesics has been consistently increasing over the past few years. The market value is projected to rise from $109.97 billion in 2024 to reach $113.96 billion in 2025, representing a compound annual growth rate (CAGR) of 3.6%. This growth in past years is due to various factors such as the influence of alternative therapies, safety and efficacy research, prevalence of pain, marketing and promotional activities, and economic conditions.

How Big Is the Analgesics Market Size Expected to Grow by 2029?
The market for analgesics is projected to witness consistent expansion in the upcoming years, with an estimated worth of $129.46 billion by 2029, growing at a compound annual growth rate (CAGR) of 3.2%. The anticipated increase in this period can be linked to elements like alternative pain management methods, stiff market competition, increased consumer awareness about health, demographic transitions, and a rise in chronic diseases. Key trends for the forecast period encompass customized medicine, non-opioid substitutes, the utilization of cb*d and cannabinoids, precise pain management, along with accessibility and affordability.

View the full report here:
https://www.thebusinessresearchcompany.com/report/analgesics-global-market-report

Which Key Market Drivers Powering Analgesics Market Expansion and Growth?
The increase in chronic diseases is significantly pushing the growth of the analgesics market. Painkiller drugs, also recognized as analgesics, are utilized to manage and lessen severe or chronic body pain arising from various health conditions. For instance, in September 2022, the World Health Organization (WHO), a Switzerland-based health entity, reported that chronic diseases, often termed as noncommunicable diseases (NCDs), are health conditions that progress over a long period due to a mix of genetic, physiological, environmental, and behavioral factors. Noncommunicable diseases (NCDs) are responsible for 41 million deaths annually, making up 74% of total deaths globally. Before reaching 70, 17 million people lose their lives to an NCD each year. These premature deaths make up 86% of the death toll in low- to mid-income countries, and 77% of NCD-related deaths take place in these nations. Hence, the increasing prevalence of chronic diseases is a significant propellant for the expansion of the analgesics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2438&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Analgesics Market?
The analgesics industry is witnessing an upward trend with companies upping their investment game in their pursuit of growth. Top-notch manufacturers of painkillers are putting their money into clinical-stage companies to better their standing in the market and get a leg up on their rivals. These investments play a pivotal role in their expansion to new regions and acquisition of specialized knowledge about research and development of novel products. As a recent example, Concentric Analgesics, Inc., a U.S. based clinical-stage biopharma company, announced in January 2022 that it completed a $20 million convertible note financing, received from a mix of new and existing investors. The funds will be used to kickstart Phase 3 registration-enabling studies for Vocacapsaicin, the company's lead product in the pipeline and ready for Phase 3. Additionally, the funds will be allocated to further the Phase 3 developmental activities for Vocacapsaicin, which is intended to be a post-surgical pain therapeutic. This completion of financing marks a significant milestone for Concentric Analgesics as it facilitates the push of Vocacapsaicin into Phase 3 development and sets the ball rolling towards securing full funding for the program through NDA submission.

What Are the Emerging Segments in the Analgesics Market?
The analgesics market covered in this report is segmented -

1) By Type: Non-opioids, Opioids
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores
3) By Application: Internal Analgesics, External Analgesics

Subsegments:
1) By Non-Opioids: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Acetaminophen (Paracetamol), Salicylates
2) By Opioids: Natural Opioids, Semi-Synthetic Opioids, Synthetic Opioids

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=2438&type=smp

Who Are the Global Leaders in the Analgesics Market?
Major companies operating in the analgesics market include Pfizer Inc., Johnson & Johnson Services Inc., Medley Pharmaceuticals Limited, AbbVie Inc., Bayer HealthCare Pharmaceuticals LLC, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Co., AstraZeneca Plc., Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical company Limited, Eli Lilly and Company, Reckitt Benckiser Group plc, Viatris Inc., Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Limited, Purdue Pharma L.P, Cipla Limited, Allergan Inc., Endo International plc, Amneal Pharmaceuticals LLC, Mallinckrodt Pharmaceuticals Ltd., Chattem Inc., Hisamitsu Pharmaceutical Co.Inc., GW Pharmaceuticals, Verve Health Care Ltd., Alder BioPharmaceuticals Inc., Achelios Therapeutics Inc., WEX Pharmaceuticals Inc., Zynerba Pharmaceuticals, McNeil Consumer & Specialty Medical Products, Innovative Med Concepts LLC

Which are the Top Profitable Regional Markets for the Analgesics Industry?
North America was the largest region in the analgesics market in 2024. Middle East is expected to be the fastest-growing region in the global analgesics market during the forecast period. The regions covered in the analgesics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2438

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.